Drug profile

The FDA adverse-event record for Acetic Acid + Boric Acid + Glycerin + Polysorbate + Triethanolamine

48 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Acetic Acid + Boric Acid + Glycerin + Polysorbate + Triethanolamine. See the species affected, top reactions, and outcomes below.

48
adverse-event reports
2.1%
death-coded share
Dog
most-reported species
24
Lack of efficacy - NOS - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
48
Total Reports
1
Deaths Reported
2.1%
Death Rate

Active Ingredients

Acetic Acid + Boric Acid + Glycerin + Polysorbate + Triethanolamine

Administration Routes

Auricular (Otic)UnknownIntraocular

Species Affected

Dog 48

Most Affected Breeds

Retriever - Labrador 7
Terrier - Yorkshire 5
Spaniel - Cocker American 4
Terrier - Jack Russell 3
Pug 3
Maltese 3
Pinscher - Miniature 2
Shepherd Dog - Australian 2
Dachshund (unspecified) 2
Poodle - Miniature 2

Most Reported Reactions

Lack of efficacy - NOS 24
Deafness 4
Impaired hearing 4
Loss of hearing 4
Vomiting 3
CULTURE/TITER DATA ABNORMAL 3
Head shake - ear disorder 3
Ear discharge 3
Other abnormal test result NOS 3
Elevated temperature 2
Behavioural disorder NOS 2
Falling 2

Outcome Breakdown

Outcome Unknown
26 (54.2%)
Ongoing
16 (33.3%)
Recovered/Normal
4 (8.3%)
Euthanized
1 (2.1%)
Recovered with Sequela
1 (2.1%)

Acetic Acid + Boric Acid + Glycerin + Polysorbate + Triethanolamine Adverse Event Insights

48 reports name Acetic Acid + Boric Acid + Glycerin + Polysorbate + Triethanolamine; 1 recorded a death outcome (2.1% of reported events, not a population-level mortality rate). Active ingredient: Acetic Acid + Boric Acid + Glycerin + Polysorbate + Triethanolamine. Administration routes: Auricular (Otic), Unknown, Intraocular.

By species: Dog (48 reports). By breed: Retriever - Labrador (7), Terrier - Yorkshire (5), Spaniel - Cocker American (4).

Leading clinical signs: Lack of efficacy - NOS (24), Deafness (4), Impaired hearing (4), Loss of hearing (4). Outcome, 48 coded reports: Outcome Unknown leads at 54.2%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.